Department of Urology, Sapporo Medical University School of Medicine, S. 1, W. 16 Chuo-ku, Sapporo, 0608543, Japan.
J Infect Chemother. 2013 Feb;19(1):50-6. doi: 10.1007/s10156-012-0450-3. Epub 2012 Jul 14.
The spread of antimicrobial-resistant Neisseria gonorrhoeae worldwide is a critical issue in the control of sexually transmitted infections. The purpose of this study was to clarify recent trends in the susceptibility of N. gonorrhoeae to various antimicrobial agents and to compare these data with our previous data. Minimum inhibitory concentrations (MICs) of various antimicrobial agents were determined in N. gonorrhoeae strains clinically isolated from male gonococcal urethritis. In addition, amino acid sequencing of penicillin-binding protein (PBP) 2, encoded by the penA gene, was analyzed so that genetic analysis of mosaic PBP 2 could clarify the susceptibility of the strains to cefixime and other cephalosporins. The susceptibility rate for ceftriaxone, cefodizime, and spectinomycin, agents whose use is recommended by the guideline of the Japanese Society of Sexually Transmitted Infections (JSSTI), was 100 %. The susceptibility rates of the strains to penicillin G and ciprofloxacin were lower than those in previous reports. Mosaic PBP 2 structures were detected in 51.9 % of the strains and the MICs of the strains with the mosaic PBP 2 to cefixime were much higher than those of the strains without the mosaic PBP 2. In the clinical situation, the treatment regimen recommended by the JSSTI remains appropriate; however, the susceptibility to cephalosporins should be intensively surveyed because strains with mosaic PBP 2 were commonly detected.
淋病奈瑟菌对抗微生物药物的耐药性在全球范围内的传播是性传播感染控制的一个关键问题。本研究的目的是阐明淋病奈瑟菌对各种抗菌药物敏感性的最新趋势,并将这些数据与我们以前的数据进行比较。从男性淋球菌性尿道炎临床分离的淋病奈瑟菌菌株中测定了各种抗菌药物的最小抑菌浓度(MIC)。此外,还分析了青霉素结合蛋白(PBP)2 的氨基酸序列,该蛋白由 penA 基因编码,以便对马赛克 PBP 2 的遗传分析能够阐明这些菌株对头孢克肟和其他头孢菌素的敏感性。日本性传播感染学会(JSSTI)指南推荐使用的头孢曲松、头孢地嗪和大观霉素的敏感性率为 100%。青霉素 G 和环丙沙星的敏感性率低于以前的报告。在 51.9%的菌株中检测到马赛克 PBP 2 结构,并且具有马赛克 PBP 2 的菌株对头孢克肟的 MIC 远高于没有马赛克 PBP 2 的菌株。在临床情况下,JSSTI 推荐的治疗方案仍然是合适的;然而,由于普遍检测到具有马赛克 PBP 2 的菌株,因此应该加强对头孢菌素敏感性的调查。